<DOC>
	<DOC>NCT01188213</DOC>
	<brief_summary>The aim of this study was to determine the efficacy of methylsulfonylmethane (MSM) in treating patients with knee OA.</brief_summary>
	<brief_title>Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of The Knee: A Randomized Controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Dimethyl sulfone</mesh_term>
	<mesh_term>Dimethyl Sulfoxide</mesh_term>
	<criteria>symptomatic knee OA for at least 6 months according to the clinical criteria of the American College of Rheumatology (ACR) radiographic confirmed knee OA according to the Kellgren &amp; Lawrence scale acute septic arthritis inflammatory arthritis any other type of arthritis history of knee buckling or recent knee injury lack of physical or mental bility to perform or comply with the treatment procedure diabetes mellitus fibromyalgia or other chronic pain syndromes concurrent anticoagulant/antiplatelet drugs arthroscopy or intraarticular injections in the previous 3 months</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2005</verification_date>
</DOC>